Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia

The American Journal of Medicine
N DeanD Hale

Abstract

We developed a pneumonia guideline at Intermountain Health Care that included admission decision support and recommendations for antibiotic timing and selection, based on the 1993 American Thoracic Society guideline. We hypothesized that guideline implementation would decrease mortality. We included all immunocompetent patients > 65 years with community-acquired pneumonia from 1993 through 1997 in Utah; nursing home patients were excluded. We compared 30-day mortality rates among patients before and after the guideline was implemented, as well as among patients treated by physicians who did not participate in the guideline program. We observed 28,661 cases of pneumonia, including 7,719 (27%) that resulted in hospital admission. Thirty-day mortality was 13.4% (1,037 of 7,719) among admitted patients and 6.3% (1,801 of 28,661) overall. Mortality rates (both overall and among admitted patients) were similar among patients of physicians affiliated and not affiliated with Intermountain Health Care before the guideline was implemented. For episodes that resulted in hospital admission after guideline implementation, 30-day mortality was 11.0% among patients treated by Intermountain Health Care-affiliated physicians compared with 14.2%...Continue Reading

References

Sep 2, 1992·JAMA : the Journal of the American Medical Association·D A DavisR B Haynes
May 1, 1982·Annals of Internal Medicine·H HalkinB Modan
Oct 1, 1995·American Journal of Respiratory and Critical Care Medicine·A M Fein, M S Niederman
Jun 1, 1994·Annals of Internal Medicine·S R TunisE P Steinberg
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jun 25, 1997·JAMA : the Journal of the American Medical Association·S Weingarten
Dec 24, 1997·JAMA : the Journal of the American Medical Association·T P MeehanJ M Fine
Dec 16, 1998·Annals of Internal Medicine·F A Lederle
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian

❮ Previous
Next ❯

Citations

Dec 20, 2003·Lancet·Thomas M File
Feb 7, 2014·The New England Journal of Medicine·Richard G Wunderink, Grant W Waterer
Mar 13, 2014·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·Elizabeth BannisterMatthew Byerly
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Nathan C DeanCarol Hadlock
Aug 7, 2007·Postgraduate Medical Journal·Paul ColliniAlastair Miller
Oct 1, 2009·Critical Care Medicine·Samuel M BrownUNKNOWN Infectious Disease Society of America/American Thoracic Society 2007
Aug 1, 2015·Postgraduate Medicine·Lionel A Mandell
Jan 21, 2016·Expert Review of Respiratory Medicine·Jordi Rello, Antonio Perez
Dec 10, 2009·Current Medical Research and Opinion·James E SignorovitchDaniel Ng
May 15, 2013·Lancet·Christopher J L MurrayAdrian Davis
Jun 26, 2012·European Journal of Internal Medicine·Jose Manuel PereiraJordi Rello
Aug 27, 2011·Clinics in Chest Medicine·Miquel FerrerAntoni Torres
Aug 27, 2011·Clinics in Chest Medicine·Mark L Metersky
Aug 28, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ami MehraCharlotte Cunningham-Rundles
Apr 15, 2008·Emergency Medicine Clinics of North America·Jesse M Pines
Aug 19, 2015·Lancet·Elena PrinaAntoni Torres
Feb 20, 2007·International Journal of Antimicrobial Agents·Hartmut LodeAntony Cockle
Nov 10, 2006·Médecine et maladies infectieuses·K Faure
Jul 19, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Samuel M BrownNathan C Dean
Mar 18, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Ali A El-SolhLilibeth A Pineda
Apr 3, 2014·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Jordan MitchellJames Hardin
Sep 14, 2004·The American Journal of Medicine·Michael S Niederman
Jul 13, 2004·International Journal of Medical Informatics·Lorrie K RoemerRichard L Bradshaw
Sep 30, 2006·The Journal of Infection·Yvonne KohlhammerUNKNOWN CAPNETZ study group
Jul 11, 2006·Archivos de bronconeumología·Alberto CapelasteguiAmaia Bilbao
Aug 9, 2005·The American Journal of Medicine·Michael T Flannery, Michael J McCool
Nov 24, 2004·Infectious Disease Clinics of North America·Mark Woodhead
Jun 2, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·David J Serisier, Simon D Bowler
Jun 6, 2007·Respiratory Medicine·Hartmut M Lode
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J GarauUNKNOWN NACER Group
Oct 16, 2007·Chest·Rosario Menendez, Antoni Torres
Oct 17, 2013·Enfermedades infecciosas y microbiología clínica·Pilar RetamarAlfonso del Arco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.